TAF Articol Rich-Lipid Diet 02.03
TAF Articol Rich-Lipid Diet 02.03
TAF Articol Rich-Lipid Diet 02.03
on high fat
diet mice -experimental study
Diana Dalina Zugravu (Pop), Stefan Lucian Popa, Andrei-Vasile Pop, Remus Moldovan, Flaviu
Tăbăran, Simona Clichici
A diet characterized by a high lipid content establishes a correlation between elevated cholesterol
levels in the bloodstream and the advancement of liver disease, specifically hepatocellular
carcinoma. Despite extensive epidemiological investigations delving into the relationship between a
lipid-rich diet and the progression of liver disease, the exact mechanism underlying hepatotoxicity
resulting from such dietary patterns remains elusive (1)
Liver disease
Chronic liver disease is mainly cause by numerous factors as: (2)
To protect liver health and prevent disease advancement, it is advisable to adhere to various
preventive measures. These measures encompass minimizing exposure to hepatotoxic agents,
refraining from alcohol consumption, implementing antiviral treatments as appropriate, and
adhering to a balanced diet (3).
Recent research underscores the heightened susceptibility of hepatic liver diseases, including
hepatocellular carcinoma, to progression in individuals experiencing overnutrition, obesity, and the
consumption of a diet rich in lipids (4).
Comprehending the mechanisms triggered by particular lipids could assist in the prevention of
hepatocellular carcinoma (1).
Cholesterol serves as a fundamental component in the human body owing to its pivotal roles in
cellular and systemic functions. Maintaining optimal functionality necessitates the maintenance of a
dynamic equilibrium among processes including uptake, biosynthesis, export, and esterification (7).
Cholesterol is synthesized through a series of enzymatic reactions within the mevalonate pathway
(8). This pathway holds significant importance in numerous cellular processes by facilitating the
synthesis of sterol isoprenoids, such as cholesterol, and non-sterol isoprenoids, including isopentenyl
tRNA, dolichol, heme-A, and ubiquinone (9).
Within the human body, cholesterol levels are governed by two distinct pathways: firstly, the hepatic
synthesis originating from acetyl-CoA through the regulation of hydroxymethylglutaryl-CoA (HMG-
CoA) reductase, and secondly, absorption from ingested food within the intestines. In cases of
excessive lipid intake, both the de novo cholesterogenesis by hepatocytes and cholesterol absorption
by enterocytes are restrained to uphold homeostasis (10).
Prior to 2015, dietary guidelines advised a consumption of up to 300 milligrams (mg) of dietary
cholesterol daily for individuals deemed healthy, and 200mg for those identified as being at high risk
of heart disease. However, as of 2015, these guidelines underwent revision, and presently, there are
no explicit recommended limits for cholesterol intake. Nonetheless, it is emphasized that there
should be constraints on the consumption of saturated and trans fats (11).
Nevertheless, determining daily cholesterol intake through the use of frequency questionnaires may
not consistently align with actual dietary consumption, and the precise mechanism underlying the
hepatotoxic effects of a lipid-rich diet remains elusive.
Gold nanoparticles
Gold nanoparticles have attracted considerable interest owing to their exceptional optical
characteristics, biocompatibility, and capacity for surface modification through the attachment of
diverse ligands (12). Recognized for their anti-inflammatory properties, gold nanoparticles are
presently under investigation in the context of patients with rheumatoid arthritis (13).
Cornus mas
Regarding Cornus mas L., it is the fruit of Cornelian cherry belonging to the Cornaceae family, with
anti-inflammatory effects, especially due to iridoids. Cornuside, a secoiridoid isolated from Cornelian
cherry, is known to reduce the mRNA of iNOS and COX-2, inhibit LPS-induced production of PGE2,
NO, IL-1β, IL-6, and TNF-α. Glycosides isolated from Cornus mas inhibit the secretion of IL-6 and IL-1,
PGE2 in rat plasma, TNF-α in peritoneal macrophages, and edema (14).
Oxidative stress
Oxidative stress is acknowledged as a unified pathological mechanism that plays a role in the onset
and advancement of liver injury. Numerous risk factors, encompassing alcohol consumption,
pharmaceutical substances, environmental contaminants, have the potential to induce oxidative
stress in the liver. This, in turn, leads to the development of serious liver conditions, including
alcoholic liver disease and non-alcoholic steatohepatitis. The utilization of antioxidants represents a
convincing therapeutic approach aimed at preventing and treating liver diseases associated with
oxidative stress (15).
Glutathione (GSH), a tripeptide primarily found in high concentrations within the liver, serves as a
pivotal thiol reducing agent crucially engaged in the regulation of redox mechanisms. Furthermore,
research has elucidated that GSH not only functions as a conventional free radical scavenger but also
actively contributes to the intricate network dictating the balance between cellular survival, necrosis,
and apoptosis (15).
The ratio between reduced glutathione (GSH) and oxidized glutathione (GSSG) serves as an indicator
of cellular healthiness (16). The extent of oxidative stress can be evaluated by measuring the levels of
malondialdehyde (MDA).
Aim
The aim of our study was to investigate the histological changes occurring shortly after the
administration of a high-fat diet compared to a control group fed a normal diet.
Subsequently, we selected several oxidative stress markers and analyzed how they are
altered following the administration of solutions containing Cornus mas and, respectively,
solutions of gold nanoparticles phytoreduced with Cornus mas, in comparison to the control
group. Simultaneously, we aimed to elucidate any potential differences between the two
types of solutions and to examine whether gold nanoparticles have a potentiating or
inhibitory effect on the Cornus mas solution, or if there is any significant difference between
them.
Methods
For our experiment we used Sprague Female rats that were fed for a period of 9 moths with high fat
diet (HFD).
Throughout the entirety of the experimental duration, a standardized lipid-rich diet of 20g/100g
body weight per day via gavage administration was employed, providing a supplemental energy
increase of 45%. Adherence to the manufacturer's specifications ensured the constituents of the diet,
encompassing L-cysteine, casein, maltodextrin, corn starch, lard, salt, cellulose, a vitamin-mineral
premix, soybean oil, calcium carbonate, choline, dye, monocalcium phosphate, and butylated
hydroxytoluene (BHT), were meticulously followed.
The caloric value of the diet was 4.75 kcal/g and consisted of 24.3% crude protein, 21.2% crude fat,
11.75% crude fiber. The diet was produced by Cantacuzino National Medico-Military Institute for
Research and Development, Bucharest, Romania, with the identification number ROB0001.
Experimental Design
We used 32 rats for randomizing divided into four groups, each group being formed of 8 rats (n=8).
The high fat diet was administrated for 32 weeks, and after that the treatment was induced for a
period of 4 weeks, according to the rats group. Our experiment ended after week 36. The treatment
was administrated to overweight rats at the beginning of week 33 due to the plan:
1. HFD received from week 33 by oral gavage for 4 weeks normal saline 0,9%
2. HFD+CM received from week 33 by oral gavage for 4 weeks cornus mas extract solution
3. HFD+ AuNPsCM received from week 33 by oral gavage for 4 weeks gold nanoparticles
phytoreduced with bioactive compounds from Cornus mas L. extract.
4. The control group received standard diet for 32 weeks, and from week 33 by oral gavage
normal saline 0.9%
Medication was administrated between 7 a.m. and 8 a.m. in an amount of 0,5mL/day by gastric tube
gavage. The amount of Cornus mas L. extract administrated was 0.158mg/ml polyohenols ) and the
amount of gold nanoparticles functionalized with bioactive compounds from Cornus mas L extract
(260 µg Au /kg/day). We also took samples of blood with K3EDTA tubes from the retrooribital plexus
of rats under mild anesthesia. Anesthesia was performed with 2.5 mg/100gbw ketamine 10% and 50
mg/100gbw of xylazine hydroxichloride 2%. The blood was centrifuged at 6,500 rmp for 10 minutes
and kept at -80 ͦ until further biochemical analysis.
In the end, we induced deep anesthesia in rats, using ketamine 10% (5mg/100gbw) and xylazine
hidroxichoride 2% ( 100mg/100gbw) to collect the liver.
Results
fel?
Control group: There are no significant findings. H&E stain, ob x 20 (left) and x 40 (right)
HFD group :There is minimal diffuse hepatocyte glycogenosis. There are no significant findings within
the portal spaces. H&E stain, ob x 20 (left) and x 40 (right)
HFD+ AuNPsCM: There is minimal zonal (mainly mod-zonal and centrilobular) glycogenosis (minimal).
There are no significant findings within the portal spaces. H&E stain, ob x 20 (left) and x 40 (right)
HFD +CM: There is minimal zonal (mainly mod-zonal) glycogenosis (minimal). There are no significant
findings within the portal spaces. H&E stain, ob x 20 (left) and x 40 (right)
Fig 1.
Fig. 2 Fig. 3
Tab. 2
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, and ***p<0.001 compared to the control group.
If we compare the MDA levels in the test group (DBL/HFD) with the HFD + CM group, we will obtain
statistical significance (***p<0,001). Similarly, comparing the MDA levels in the test group (DBL) with
the HFD + AuNPsCM group will yield statistical significance (***p<0,001). Moreover, comparing the
MDA levels in the HFD + CM group with the control group results in statistical significance (**p<0,01).
Likewise, comparing the MDA levels in the HFD + AuGNPsCM group with the control group will yield
statistical significance (**p<0,01). By comparing the MDA value in the test group (DBL) with the
Control group, statistical significance was observed between the two groups (*p<0,05). However,
comparing the MDA levels between the two groups, HFD + CM and HFD + AuGNPsCM, does not yield
statistical significance.
Elevated levels of malondialdehyde (MDA) were noted (*p<0.05, **p<0.01, and ***p<0.001) in the
groups subjected to a high-fat diet (HFD/DBL), HFD+CM, and HFD+ AuNPsCM, in comparison to the
control group. Upon comparing MDA levels between the HFD+CM and HFD+ AuNPsCM groups, no
statistically significant differences were detected. In the groups where CM or AuGNPsCM were
administered, the MDA levels exhibited a significant decrease compared to the test group.
Tab. 3
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, ***p<0.001 ****p< 0,0001 compared to the control group.
If we compare the TNF alpha (tumor necrosis factor) value between the test group DBL and the
HFD+CM group, statistical significance will be observed (****p<0.0001). However, if we compare the
TNF alpha value between the test group DBL and the HFD+AuNPsCM group, no statistical significance
will be evident between the two groups. Moreover, comparing the test group DBL with the control
group yields a p-value of <0.0001, indicating statistical significance between these two groups.
Furthermore, if we compare the control group with both the HFD+CM group and the HFD+AuNPsCM
group, statistical significance (****p<0,0001) will be evident regarding each individual comparison
with the control group. However, when comparing them with each other, HFD+CM and
HFD+AuNPsCM, no statistical significance will be observed regarding the TNF alpha value between
the two groups. TNF alfa was surprisingly increased in study compared to control.
Fig. 4 Fig. 5
Tab 4.
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, and ***p<0.001 compared to the control group.
Regarding IL-1 alpha (Interleukin-1 alpha), there were no statistically significant differences observed
when comparing the test group with the control group, as well as when comparing the test group
with the HFD+CM group. However, a statistically significant difference was noted (*p<0.05) when
comparing the test group (DBL) with the HFD+AuNPsCM group. Furthermore, no statistical
significance was found when comparing the IL-1 alpha value in the control group with the HFD+CM
group. Conversely, statistical significance (*p<0,05) was obtained when comparing the IL-1 alpha
value in the control group with the HFD+AuNPsCM group. Additionally, a slight statistical significance
(*p<0.05) was observed when comparing the IL-1 alpha value in the two groups, HFD+CM and
HFD+AuNPsCM.
Tab. 5
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, and ***p<0.001 compared to the control group.
When comparing the toll-like receptor 4 (TLR4) value between the test group (DBL) and the control
groups, HFD+CM, as well as with the HFD+AuNPsCM group, a statistically significant difference of
considerable magnitude was observed between the test group and each of the three groups
(***p<0.001). Comparing the TLR4 value between the control group and the HFD+CM group revealed
a strong statistical significance (***p<0.001). The most robust statistical significance was observed
between the control group and the HFD+AuNPsCM group (****p<0.0001) concerning the TLR4 value.
Additionally, a slight statistical significance was observed between the HFD+CM group and the
HFD+AuNPsCM group regarding the TLR4 value (*p<0.05).
Fig. 6 Fig. 7
Tab. 6
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, and ***p<0.001 compared to the control group.
When comparing the value of reduced glutathione and its ratio with oxidized glutathione (GSH/GSSG)
between the test group (DBL) and HFD + CM, as well as between the test group (DBL) and HFD+
AuNPsCM, a slight statistical significance was observed (*p<0.05). Regarding the control group, only a
slight statistical significance was obtained (*p<0.05) when compared to the test group (DBL)
concerning the value of GSH/GSSG. No statistical significance was observed between the control
group and the other groups: HFD+CM and HFD + AuNPsCM.
Tab. 7
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, and ***p<0.001 compared to the control group.
When comparing the value of glutathione peroxidase (GPX) between the test group (DBL) and HFD +
CM, no statistical significance was observed; however, a slight statistical significance (*p<0.05) was
noted between the test group (DBL) and HFD+ AuNPsCM. Regarding the control group, only a slight
statistical significance (*p<0.05) was obtained when compared to the test group (DBL) concerning the
value of GPX. No statistical significance was observed for the value of GPX between the control group
and the other groups: HFD+CM and HFD + AuNPsCM.
Fig. 8 Fig. 9
Tab. 8
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, and ***p<0.001 compared to the control group.
When comparing the studied groups, no statistical significance was obtained regarding the value of
catalase.
Tab. 9
The data underwent analysis via one-way ANOVA, subsequently followed by Tukey's multiple
comparisons posttest utilizing GraphPad Prism 9.3.1 software (GraphPad, San Diego, USA). Results
were presented as means with standard deviation (±S.D.); significance levels were denoted as
*p<0.05, **p<0.01, and ***p<0.001 compared to the control group.
When comparing the value of hyaluronic acid between the test group (DBL) and the HFD+CM group,
as well as between DBL and HFD+AuNPsCM, no statistically significant difference was observed.
However, a slight statistical significance (*p<0.05) was obtained when comparing the value of
hyaluronic acid in the test group (DBL) with the control group. Comparing the value of hyaluronic
acid in the control group with both the HFD+CM group and the HFD+AuNPsCM group yielded a
strong statistical significance (***p<0.001). No statistical significance was found between the
HFD+CM and HFD+AuNPsCM groups regarding the value of hyaluronic acid.
Discussion
In our study, we endeavored to examine the hepatic alterations resulting from a high-lipid diet
compared to a control group receiving a standard diet. Moreover, we sought to investigate whether
the administration of Cornus mas solution and AuGNPsCM solution yielded any hepatic
improvements in the rats to which they were administered. Despite the relatively brief duration of
administration of the CM and AuGNPSCM solutions in our experiment, subtle enhancements in
hepatic structure, particularly centrolobular, were discernible.
It can be observed that, compared to other studies in the literature (17), the group administered a
high-fat diet (HFD) exhibited the presence of hepatic steatosis (18).
In a study conducted by Romestaig et al. in 2007, it was found that a high-fat diet failed to induce
NASH or liver steatosis in experimental animals. This observation was attributed to the presence of
hepatic mitochondria expressing energy dissipation, which potentially mitigates steatosis and
oxidative stress (19).
Furthermore, another study suggests that NASH/NAFLD resulting from a lipid-rich diet is often
characterized by high instability and, at times, mild manifestations. The severity of this condition
appears to be strongly influenced by various factors including the duration and composition of the
high-fat diet, as well as the species, age, strain, and gender of the animals (5).
In their study, Nishikawa et al. observed that middle-aged C57BL/6 mice demonstrated elevated
hepatic lipid accumulation and a higher fat body weight ratio compared to their younger
counterparts. Moreover, a comparison between two mouse strains revealed that C57BL/6J male
mice exhibited lower liver lipid accumulation than BALB/c male mice (20).
On the contrary, a study conducted by Lieber et al. in 2004 investigated the effects of administering a
high-fat liquid diet to Sprague Dawley rats. Their findings revealed that after 3 weeks of dietary
intervention, the rats exhibited mild steatosis compared to those on a standard diet, with the liver
returning to a normal state post-experimentation. Additionally, the high-fat diet induced
mononuclear inflammation, abnormal mitochondrial morphology, and elevated levels of hepatic
tumor necrosis factor-alpha, collagen type 1, and oxidative stress markers, including heightened
levels of 4-hydroxynonenal (21).
The initiation of intracellular oxidative stress by oxidized low-density lipoprotein, via lipid
peroxidation products, triggers enhanced synthesis of the p53 protein and subsequent activation of
the tumor suppressor p53. These cellular responses likely stem from the cytotoxic effects of oxidized
low-density lipoprotein, as p53 activation elicits necrotic and apoptotic outcomes (22).
In a study conducted in 2018, Hui Chen et al. explored the utilization of gold nanoparticles for their
anti-inflammatory properties in mitigating weight gain in mice subjected to a high-fat diet. Their
findings indicated a shift in adipose macrophages from the M1 to M2 phenotype, potentially
contributing to weight reduction. Although the hypothesis remained unproven, the researchers
concluded that mice treated with gold nanoparticles while on a high-fat diet exhibited protection
against glucose intolerance and hyperlipidemia (13).
Recent research has highlighted the hepatoprotective effects of anthocyanins derived from cornelian
cherry fruit extract in animal experimental models, suggesting a potential impact on non-alcoholic
fatty liver disease (NAFLD) (23). An additional study highlighted the antioxidant properties of Cornus
mas L., attributed to its antioxidant constituents. These components have been shown to restore
aberrant biochemical profiles and promote membrane stabilization when subjected to CCl4
exposure, thereby demonstrating its therapeutic potential in the management of liver disorders (24).
Oxidative stress arises from an inequality between the generation of free oxygen radicals and their
neutralization by the antioxidant defense system. This imbalance has the potential to inflict damage
on various cellular and extracellular components (25). Oxidative stress is recognized as a collective
pathological mechanism that plays a role in both the onset and progression of liver injury (26).
Malondialdehyde (MDA) serves as a biomarker for assessing oxidative stress levels in diverse
biological samples (27).
Comparing our MDA values with the literature (28) we obtained similar results in our study, the MDA
value increases following the administration of HFD compared to the control group, while after the
administration of solutions with Cornus mas or solutions with gold nanoparticles functionalized with
Cornus mas, its value begins to decrease compared to the control group.
Conclusion
Our investigation highlights the incidence and progression of histological alterations observed in an
experimental model involving the administration of a high-fat diet to rats. Furthermore, we elucidate
the evolution of these histological changes subsequent to the administration of Cornus mas solution
and AuNpsCM solution. In our study, we monitored the evolution of oxidative stress markers and
arrived at the following conclusions: The MDA value significantly decreased in groups with HFD
administered with CM and AuNPsCM solutions, with no statistically significant difference between
the two. The TNF-alpha value markedly increased in groups with HFD administered with CM solution
and AuNPsCM solution, without statistically significant evidence between the two solutions. The IL1-
alpha value showed a slight statistically significant increase in the HFD group administered with CM
solution and in the HFD group administered with AuNPsCM solution, with a slight statistically
significant difference between the two solutions, indicating a slight superiority of the CM solution.
Regarding the TLR4 value, there was a significant increase with the administration of CM and
AuNPsCM solutions in the HFD group, with a slight statistical significance between the two solutions,
with the AuNPsCM solution being slightly more statistically significant. We also tested the GSH/GSSG
ratio, where no statistically significant differences were found between the control group and the
HFD groups administered with CM and AuNPsCM solutions. The only slightly statistically significant
differences were obtained when administering the solutions to the test group (DBL), with a slight
statistical significance observed between the GSH/GSSG ratio values of the test group and the control
group. Similar results to those observed for the GSH/GSSG ratio were obtained for GPX as well.
Regarding catalase, in the case of our groups, statistically significant values were not obtained. We
obtained statistically significant results regarding the value of hyaluronic acid. Comparing the control
group with the HFD groups administered either CM or AuNPsCM solutions, there was a significant
increase in both cases, with no statistically significant difference between the two solutions in our
results.
References
2. Liver Disease: Types of Liver Problems & Their Causes [Internet]. [cited 2024 Mar 2]. Available from:
https://www.webmd.com/hepatitis/liver-and-hepatic-diseases
3. Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, et al. Mild drinking habit is a risk
factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. World J
Gastroenterol [Internet]. 2018 Mar;24(13):1440. Available from: /pmc/articles/PMC5889824/
4. Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, et al. Clinicopathological
characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Hepatol Res [Internet]. 2017 Mar;47(5):405–18. Available from:
https://pubmed.ncbi.nlm.nih.gov/27288988/
5. Takahashi Y, Fukusato T. Animal Models of Liver Diseases. Animal Models for the Study of Human
Disease: Second Edition. 2017 Mar;313–39.
6. Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and
the incidence of cirrhosis or liver cancer in the united states population. Hepatology [Internet]. 2009
Mar;50(1):175–84. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/hep.22941
7. Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nature Reviews
Molecular Cell Biology 2019 21:4 [Internet]. 2019 Mar;21(4):225–45. Available from:
https://www.nature.com/articles/s41580-019-0190-7
8. Cruz PMR, Mo H, McConathy WJ, Sabnis N, Lacko AG. The role of cholesterol metabolism and
cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer
therapeutics. Front Pharmacol. 2013;4 SEP:119.
9. Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin
Biochem [Internet]. 2007 Mar;40(9–10):575–84. Available from:
https://pubmed.ncbi.nlm.nih.gov/17467679/
10. Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol [Internet].
2015 Mar;15(2):104–16. Available from: https://pubmed.ncbi.nlm.nih.gov/25614320/
12. Taghizadeh S, Alimardani V, Roudbali PL, Ghasemi Y, Kaviani E. Gold nanoparticles application in liver
cancer. Photodiagnosis Photodyn Ther [Internet]. 2019 Mar;25:389–400. Available from:
https://pubmed.ncbi.nlm.nih.gov/30684673/
13. Chen H, Ng JPM, Tan Y, McGrath K, Bishop DP, Oliver B, et al. Gold nanoparticles improve metabolic
profile of mice fed a high-fat diet. J Nanobiotechnology [Internet]. 2018 Mar;16(1). Available from:
https://pubmed.ncbi.nlm.nih.gov/29409496/
14. Majdan M, Bobrowska-Korczak B. Active Compounds in Fruits and Inflammation in the Body.
Nutrients 2022, Vol 14, Page 2496 [Internet]. 2022 Mar;14(12):2496. Available from:
https://www.mdpi.com/2072-6643/14/12/2496/htm
15. Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in Glutathione Content
in Liver Diseases: An Update. Antioxidants 2021, Vol 10, Page 364 [Internet]. 2021 Feb 28 [cited 2024
Mar 2];10(3):364. Available from: https://www.mdpi.com/2076-3921/10/3/364/htm
16. Owen JB, Allan Butterfiel D. Measurement of oxidized/reduced glutathione ratio. Methods in
Molecular Biology [Internet]. 2010 [cited 2024 Mar 2];648:269–77. Available from:
https://link.springer.com/protocol/10.1007/978-1-60761-756-3_18
17. Sasidharan SR, Joseph JA, Anandakumar S, Venkatesan V, Ariyattu Madhavan CN, Agarwal A.
Ameliorative potential of Tamarindus indica on high fat diet induced nonalcoholic fatty liver disease
in rats. The Scientific World Journal. 2014;2014.
18. Zhang X, Xu GB, Zhou D, Pan YX. High-fat diet modifies expression of hepatic cellular senescence gene
p16(INK4a) through chromatin modifications in adult male rats. Genes Nutr [Internet]. 2018 Mar 14
[cited 2024 Mar 2];13(1):1–12. Available from:
https://genesandnutrition.biomedcentral.com/articles/10.1186/s12263-018-0595-5
19. Romestaing C, Piquet MA, Letexier D, Rey B, Mourier A, Servais S, et al. Mitochondrial adaptations to
steatohepatitis induced by a methionine- and choline-deficient diet. Am J Physiol Endocrinol Metab
[Internet]. 2008 Mar;294(1). Available from: https://pubmed.ncbi.nlm.nih.gov/17986629/
20. Nishikawa S, Sugimoto J, Okada M, Sakairi T, Takagi S. Gene Expression in Livers of BALB/C and
C57BL/6J Mice Fed a High-Fat Diet. http://dx.doi.org/101177/0192623311422078 [Internet]. 2011
Mar;40(1):71–82. Available from: https://journals.sagepub.com/doi/10.1177/0192623311422078
21. Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, et al. Model of nonalcoholic steatohepatitis. Am J
Clin Nutr [Internet]. 2004 Mar;79(3):502–9. Available from:
https://academic.oup.com/ajcn/article/79/3/502/4690157
22. Mazière C, Meignotte A, Dantin F, Conte MA, Mazière JC. Oxidized LDL Induces an Oxidative Stress
and Activates the Tumor Suppressor p53 in MRC5 Human Fibroblasts. Biochem Biophys Res
Commun. 2000 Mar;276(2):718–23.
24. Alavian SM, Banihabib N, Haghi MEs, Panahi F. Protective Effect of Cornus mas Fruits Extract on
Serum Biomarkers in CCl4-Induced Hepatotoxicity in Male Rats. Hepatitis Monthly 2014 14:4
[Internet]. 2014 Mar;14(4):10330. Available from: https://brieflands.com/articles/hepatmon-
15272.html
25. Fatih Canakci Yasin Cicek Abdulkadir Yildirim Ufuk Sezer Varol Canakci C, Fatih Çanakçı Atatürk
Universitesi C, Hekimligi Fakultesi D. Increased Levels of 8-Hydroxydeoxyguanosine and
Malondialdehyde and its Relationship with Antioxidant Enzymes in Saliva of Periodontitis Patients.
Eur J Dent [Internet]. 2009 Apr [cited 2024 Mar 2];3(2):100. Available from:
/pmc/articles/PMC2676068/
26. Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW, et al. The Role of Oxidative Stress and Antioxidants
in Liver Diseases. International Journal of Molecular Sciences 2015, Vol 16, Pages 26087-26124
[Internet]. 2015 Nov 2 [cited 2024 Mar 2];16(11):26087–124. Available from:
https://www.mdpi.com/1422-0067/16/11/25942/htm